Dyadic International to participate at Wall Street Analyst Forum
24 Feb '06
1 min read
Dyadic International Inc, a biotechnology company engaged in the development, manufacture and sale of biological products, announced that its President and CEO, Mark Emalfarb, will present at The Wall Street Analyst Forum.
When: On February 27th - March 2nd, 2006 at The Princeton Club on 15 West 43rd St. in New York.
Where: The presentation will take place at 9:40 a.m. EST on Wednesday, March 1st 2006 at http://www.dyadic-group.com.
Dyadic International Inc is engaged in the development, manufacture and sale of proteins, enzymes and other bio-molecules, as well as the licensing of its enabling proprietary technology to collaborators for the discovery, development and manufacture of biological products from genes.
Dyadic markets its products and services for applications in the textile, chemical, agricultural, pulp & paper, pharmaceutical, biotechnology and other industries, using its proprietary C1 Host Technology and C1 Expression and Screening Systems for the discovery, development and production of biological products.